← Back to headlines
GLP-1 Drugs May Reduce Cancer Risk, New Research Suggests
New research indicates that GLP-1 medications, commonly used for type 2 diabetes and weight loss, could be associated with a decreased risk of developing certain types of cancer.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
%2CxPosition%3D.5%2CyPosition%3D.5%3BResize%3D(1200%2C675)%26impolicy%3Dmedium&w=828&q=75&output=webp&default=1)
